An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000008369
- Lead Sponsor
- Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 38
Not provided
1)Patients with allergies to insulin aspart or detemir 2)None type 2 diabetes 3)Medical history and/or complication of diabetic ketoacidosis 4)Medical history and/or complication of severe hypoglycemia 5)Treatment with insulin, DPP-4 inhibitor or GLP-1 analogue within 4 weeks prior to the study 6)Treatment with glucocorticoid 7)Uncontrolled hypertension (systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg) 8)Patients with proliferative retinopathy or maculopathy 9)Medical history and/or malignancy 10)Severe complications and problems not suitable for the study 11)Pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method M values
- Secondary Outcome Measures
Name Time Method